Drug Trial Radar · NCT05507645
ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)
Last checked: Nov 20, 2026Latest source record: Sep 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,446
Actual
Start
Nov 15, 2022
Primary completion
Mar 26, 2024
Study completion Jun 17, 2024
Sponsor
- Lead sponsor
- Beijing Tiantan HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 19, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the safety and efficacy of rhPro-UK (35mg) versus standard medical treatment in acute mild ischemic stroke within 4.5 hours of symptom onset.
Conditions
- Ischemic Stroke
- Mild
- Thrombosis
Interventions
Recombinant Human Prourokinase for Injection (rhPro-UK)Drug
15mg of rhPro-UK intravenous bolus within 3 minutes, and the remaining 20mg intravenous drip within 30 minutes.
standard medical treatmentDrug
Standard antiplatelet or anticoagulant treatment at the discretion of local investigators.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The modified Rankin Scale score (mRS) ≤ 1 at 90 daysTime frame: 90 days
Locations
89 sites in 1 country. Site status is shown where the registry gives one.
Taihe Hospital of Traditional Chinese Medicine
Fuyang, Anhui, China
Lujiang County People's Hospital,Anhui Province
Hefei, Anhui, China
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
The First Hospital of Fangshan District, Beijing
Beijing, Beijing Municipality, China
Chongqing Sanbo Chang 'an Hospital
Chongqing, Chongqing Municipality, China
Dingxi People's Hospital
Dingxi, Gansu, China
Jiuquan City People's Hospital
Jiuquan, Gansu, China
Guangdong Second Provincial General Hospital
Guangzhou, Guangdong, China
Heyuan People's Hospital
Heyuan, Guangdong, China
People's Hospital of Huazhou
Maoming, Guangdong, China
Wuchuan People's Hospital
Zhanjiang, Guangdong, China
Wuming Hospital of Guangxi Medical University
Nanning, Guangxi, China
The Second People's Hospital of Guiyang
Guiyang, Guizhou, China
The Second Affiliated Hospital of Guizhou Medical University
Kaili, Guizhou, China
The People's Hospital of the Qiandongnan Miao and Dong Autonomous Prefecture
Kaili, Guizhou, China
Affiliated Hospital of Hebei University
Baoding, Hebei, China
Hebei Tang County People Hospital
Baoding, Hebei, China
Chengde Central Hospital
Chengde, Hebei, China
Long Hua Xian Yi Yuan
Chengde, Hebei, China
Fengning Manchu Autonomous County Hospital
Chengde, Hebei, China
Wei Xian Ren Min Yi Yuan
Handan, Hebei, China
The People's Hospital of Changli County
Qinhuangdao, Hebei, China
The Second Hospital of Qinhuangdao
Qinhuangdao, Hebei, China
Xingtang People's Hospital
Shijiazhuang, Hebei, China
Yuanshi Hospital of Traditional Chinese Medicine
Shijiazhuang, Hebei, China
The Second Hospital of Xinji
Shijiazhuang, Hebei, China
Xinji Hospital of T.C.M
Shijiazhuang, Hebei, China
Linxi Hospital of Kailuan General Hospital
Tangshan, Hebei, China
Luanzhou People's Hospital
Tangshan, Hebei, China
Tangshan Guye Traditional Chinese Medicine Hospital
Tangshan, Hebei, China
Tangshan Fengnan District Hospital
Tangshan, Hebei, China
Yu Tian Xian Zhong Yi Yi Yuan
Tangshan, Hebei, China
Zunhua People's Hospital
Tangshan, Hebei, China
The People's Hospital of Qianxi County
Tangshan, Hebei, China
Weixian People's Hospital
Xingtai, Hebei, China
The Greatwall Hospital
Xingtai, Hebei, China
Center Hospital·Jiamusi
Jiamusi, Heilongjiang, China
Central Hospital·Jiaozuo
Jiaozuo, Henan, China
The Second People's Hospital of Jiaozuo
Jiaozuo, Henan, China
Jiyuan Hospital of Traditional Chinese Medicine
Jiyuan, Henan, China
Showing 40 of 89 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.